The Inotrope Evaluation and Research Patient Registry

CompletedOBSERVATIONAL
Enrollment

129

Participants

Timeline

Start Date

August 25, 2014

Primary Completion Date

September 30, 2021

Study Completion Date

September 30, 2021

Conditions
Heart Failure
Interventions
DRUG

Inotrope

Home intravenous infusion of Dobutamine, Dopamine, or Milrinone

Trial Locations (5)

10029

Icahn School of Medicine at Mount Sinai, New York

10032

Columbia University Medical Center/Vivian and Seymour Milstein Family Heart Center, New York

35294

University of Alabama at Birmingham, Birmingham

60611

Northwestern University, Bluhm Cardiovascular Institute, Chicago

66160

The University of Kansas Medical Center Research Institute, Kansas City

Sponsors
All Listed Sponsors
collaborator

Columbia University

OTHER

collaborator

Northwestern University

OTHER

collaborator

University of Kansas Medical Center

OTHER

collaborator

University of Alabama at Birmingham

OTHER

collaborator

Icahn School of Medicine at Mount Sinai

OTHER

lead

Coram Clinical Trials

OTHER